COMPANY




News Releases


Archives
  • 2004
  • 2002 - 2003
  • 2000 - 2001
  • 1998 - 1999
  • Medical University Of South Carolina Goes Live On New Velos Transplant Release

    Fremont, CA — May 31, 2006 — Velos, Inc., an innovative provider of clinical research and specialty medical software, today announced that Medical University Hospital Authority of the Medical University of South Carolina (MUSC) rolled out a major new release of the Velos Transplant product line. Working closely with MUSC and others in the Velos Transplant User Group, Velos introduced a series of product enhancements that adds further depth and power to the Velos Transplant product line. Noteworthy enhancements were made in such areas as patient dashboards, search functions, role-based security and user management, HLA, PRA & Unacceptable Antigen functions, medical record merge capabilities, and organ mapping.

    “The Velos system has been very well received in our Transplant Center. We anticipate improvements in both efficiency and patient care.” says Dave Northrup, Director of Clinical Systems, Office of the CIO at MUSC.

    “We feel very fortunate to be working closely with MUSC,” says John S. McIlwain, President, Velos, Inc. “MUSC’s contributions have been substantial, and we look forward to continued collaboration.”

    "From the first day of go-live, the Velos system has had a positive impact on our ability to access patient information and more efficiently track this complex patient population. We can now access our patient information from any computer in any location that has internet access,” notes Sylvia Odom, MUSC Transplant Systems Analyst and Clinical Outcomes Manager. “This capability is the greatest asset to our staff. We look forward to the continued collaboration with Velos for other design enhancements that will add to the application's efficiency and to ours."

    About MUSC

    The Medical University of South Carolina, established in 1824, is the oldest medical college in the South. Today, much of the medical education of the University takes place in conjunction with the Medical University Hospital Authority. As an academic medical center, MUSC prides itself on providing the highest level of patient care, while shaping the future of medicine through education, and participating in ever-increasing levels of important clinical research. The Medical Center employs the widest range of specialists in South Carolina. It includes four hospitals - Medical University Hospital, Children's Hospital, Charleston Memorial Hospital and the Institute of Psychiatry. MUSC also includes a variety of centers and services such as Heart & Vascular, Hollings Cancer Center, Storm Eye Institute, Digestive Disease Center, Transplant, Otolaryngology, Neurosciences and Women's Health. Overall, the MUSC system accounts for approximately 600 inpatient beds, and numerous outpatient clinics, facilities and services, both on the MUSC campus and extending into the community, providing over 750,000 ambulatory care visits per year.

    MUSC is the only provider of multi-organ transplant services in the State of South Carolina. The annual volume places MUSC firmly in the top 10% of centers ranked by volume, and the clinical outcomes program has gained a national reputation for the Transplant Center at MUSC.

    About Velos

    Velos, Inc., http://www.velos.com/.,is a leading provider of next-generation healthcare software. Velos develops, markets, and supports an integrated suite of clinical, administrative, and financial products. Velos eResearch , the company’s flagship clinical trial management product line, has been chosen by leading medical centers in academic medicine and research. Velos’ specialty medical product line supports the information needs of healthcare providers in cardiology, cardiovascular surgery, dialysis, and transplantation. Velos is privately held with headquarters in Fremont.

    This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements.

    Additional information regarding Velos may be obtained by contacting Madalynne Chapman (510-580-2661 / mchapman@velos.com) or visit http://www.velos.com/.